Kristen Kloosterman, NP
Women's Health · West Seneca, NYNPI 1952563363
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,199 of the $2,464 with a category attached, or 89.3%. It is spread thinly across 23 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. Among women's health clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 124 payments — averaging $19.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$475
- Mayne Pharma Commercial LLC$392
- AbbVie$210
- Millicent US Inc$157
- Agile Therapeutics, Inc.$143
- Amgen$130
- plus $956 from 17 others
What the payments were for
- Food & beverage$2,19989%
- Education$26511%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 16 | $475 |
| Mayne Pharma Commercial LLC | 28 | $392 |
| AbbVie | 9 | $210 |
| Millicent US Inc | 6 | $157 |
| Agile Therapeutics, Inc. | 7 | $143 |
| Amgen | 8 | $130 |
| Bayer | 7 | $113 |
| Scynexis, Inc. | 6 | $106 |
| Mylan Pharmaceuticals Inc. | 5 | $98 |
| Therapeuticsmd, Inc. | 5 | $83 |
| Pfizer | 5 | $83 |
| Exeltis, USA Inc. | 4 | $83 |
| Organon | 3 | $67 |
| Merck | 3 | $56 |
| Gilead | 2 | $48 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $45 |
| Exact Sciences | 2 | $44 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| Evofem Biosciences, Inc. | 1 | $24 |
| Coopersurgical, Inc. | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Dexcom, Inc. | 1 | $19 |
| Myovant Sciences Inc. | 1 | $19 |
How this compares
$2,464 in reported general payments places this provider in the 90th percentile of 376 women's health providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VeozahFezolinetant | 12 | $8,474 |
| PremarinEstrogens, Conjugated | 16 | $6,633 |
| Estradiol | 56 | $4,563 |
| Estradiol (Twice Weekly)Estradiol | 13 | $1,750 |
| Medroxyprogesterone Acetate | 25 | $717 |
| ValacyclovirValacyclovir Hcl | 33 | $711 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 22 | $373 |
| Nystatin | 16 | $298 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 16 | $290 |
| Alendronate Sodium | 19 | $217 |
| Metronidazole | 20 | $183 |
| Fluconazole | 43 | $112 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 12 | $84 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncVeozah | $475 | $8,47412 claims |
| PfizerPremarin | $83 | $6,63316 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 376 women's health providers in New York.
Other women's health in West Seneca
- Sophia FrontusBrooklyn$52K
- Austin JacobusNew York$51K
- Jenna HortonAlbany$37K
- Stacie WierWilliamsville$12K
- Jenna GoldsmithWilliamsville$9K
- Mollie FinkelAlbany$7K
- Marjorie Seale-SimpsonMiddletown$6K
- Stacy GarrityNew York$5K
- Sarah WeldNew York$5K
- Kathleen CsillagNew York$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.